VAERS reports by lot

GSK DTaP/Tdap lot 24T2N: VAERS reports

56 VAERS reports list lot 24T2N as a GSK DTaP/Tdap vaccine, received between 2021-09-08 and 2023-06-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
56
Reports
0%
Marked serious
0
With a death outcome
21
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1774%
Allergic / Anaphylactic29%
Dermatological (non-injection-site)29%
Psychiatric / Neuropsychiatric14%
General / Systemic (non-local)14%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan10
Ohio5
Colorado4
Pennsylvania4
Missouri3
California2
Illinois2
Iowa2
West Virginia2
Oklahoma2
Hawaii2
Wisconsin2

Reports by month received

2021-092
2021-101
2021-112
2021-122
2022-013
2022-021
2022-031
2022-043
2022-057
2022-075
2022-084
2022-092
2022-102
2022-112
2022-122
2023-011
2023-021
2023-033
2023-043
2023-056
2023-063

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.